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Abstract 
Case report and literature review on T-cell acute 
lymphoblastic leukemia with 
t(7;14)(p15;q11.2)/HOXA-TCRA/D and biallelic 
deletion of CDKN2A. 
Clinics 
Age and sex 
9 years old male patient. 
Previous history 
No preleukemia, no previous malignancy, no inborn 
condition of note, no main items.  
Organomegaly 
No hepatomegaly, splenomegaly, enlarged lymph 
nodes, no central nervous system involvement.  
Note 
Positive for splenomegaly, bilateral enlarged 
kidneys, large mediastinal mass, extensive 
lymphadenopathy of intrathoracic, retroperitoneal, 
cervical, and axillary regions.  
Cerebral spinal fluid negative for malignant cells. 
Blood 
WBC: 31.6 X 109/l 
HB: 8.6g/dl 
Platelets: 15 X 109/l 
Blasts: 65% 
Bone marrow: Dry tap. 
Note: Peripheral blood showed anemia, 
thrombocytopenia and leukocytosis. 
Cyto-Pathology 
Classification 
Cytology 
Peripheral blood smear showed large L2 
lymphoblasts with nucleoli, normochromic, 
normocytic RBCs and markedly decreased 
platelets. 
Immunophenotype 
Flow cytometric analysis of peripheral blood 
demonstrated an abnormal CD45dim circulating 
lymphoblasts (75%) expressing CD2, CD5, CD7, 
CD8, CD10, cytoplasmic CD3, TdT and partially 
expressing weak CD30.  
Overall, these findings were consistent with T-cell 
malignancy. 
Rearranged Ig Tcr 
No rearrangements of TCRB and TCRA/D genes 
by FISH. 
Electron microscopy 
Not performed. 
Diagnosis 
T-cell acute lymphoblastic leukemia (T-ALL). 
Survival 
Date of diagnosis: 09-2013 
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Treatment: Patient was treated with COG-
AALL00434 protocol including vincristine, 
daunorubicin hydrochloride, prednisone, 
pegaspargase, and intrathecal cytarabine and 
methotrexate. 
Complete remission: yes 
Treatment related death: no  
Relapse: no  
Status: Alive. Last follow up: 01-2014 
Survival: 4 months 
Note: In remission; on maintenance chemotherapy 
as of Jan 28, 2014. 
Karyotype 
Sample: Peripheral blood 
Culture time: 24 and 48hrs unstimulated cultures 
Banding: GTG 
Results 
46, 
XY,del(6)(q14q21),t(7;14)(p15;q11.2),del(9)(p13)[
12]/92,idemx2,[7]/46,XY[1] (Figure 1) 
Other molecular cytogenetics technics 
Fluorescence in situ hybridization (FISH) 
FISH using Vysis LSI BCR/ABL, CDKN2A/CEP-9 
and TCRA/D, as well as Cytocell TCRB DNA 
probes was performed on peripheral blood 
harvested pellet.  
FISH analysis revealed four copies for TCRB/7q34, 
TRA/D/14q11.2, BCR/22q11.2, and ABL/9q34 in 
approximately 50% of cells, representing the 
pseudotetraploid cell line observed by karyotype. 
No BCR/ABL gene fusion was detected in any cell 
line. The hybridization with the CDKN2A/CEP9 
probe set produced nullisomy (biallelic loss) of the  
CDKN2A in 79% of cells but four copies of the 
control CEP-9 in 44% of cells and two copies in the 
remaining 35% while the normal cells had 2 copies 
of each (Figure 2). 
To verify the results of chromosome analysis with 
respect to t(7;14), confirmatory FISH was 
performed using Signature Genomic DNA probes 
BAC probes RP11-1132K14/7p15 (orange) 
covering the HOXA cluster genes and CTD-
2555K7/14q11.2 (green) laying immediately 
telomeric to the TCRA/D/14q11.2 coding region. 
The hybridization revealed a fusion pattern; one 
fusion signal in the pseudodiploid and two fusion 
signals in the pseudotetraploid cells (Figure 3). 
Array Comparative Genomic Hybridization 
(aCGH) 
Genomic DNA was isolated from peripheral blood 
using a Puregene kit (Gentra Systems, Minneapolis, 
MN). The aCGH was performed using a genome 
wide oligonucleotide + single nucleotide 
polymorphism based microarray containing 180K-
features (SurePrint G3 GGXChip + SNP v1.0 
4x180k Agilent Technologies, St Clara, CA). The 
microarray slide was scanned by Agilent G2565 
CA microarray scanner system with data imported 
to aCGH Analytics Software (Genoglyphix™; 
Signature Genomic Laboratories). The array design 
and genomic coordinates are based on NCBI build 
37 (hg19). 
The aCGH revealed a 33.3Mb terminal monoallelic 
deletion of chromosome 9p13.3->pter, with 1.39 
Mb biallelic deletions in the 9p21.3 region which 
spans the CDKN2A gene locus (Figure 4). It also 
detected a large 20.7 Mb interstitial deletion at 
del(6)(q14.1q16.2) and 1.34 Mb duplication within 
the 4q32.1 region. 
 
Figure 1: G-banded karyotype of the pseudodiploid cell line demonstrating del(6q) (hollow arrow), t(7;14)(p15;q11.2) (thin 
arrows), and del(9p) (solid arrow).  
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Figure 2: FISH was performed using CDKN2A (orange) and the control CEP 9 (green) DNA probe set. The hybridization 
revealed biallelic loss of CDKN2A in an abnormal metaphase (long arrow) while the normal diploid interphase cell had two copies 
of each (short arrow). 
 
 
Figure 3: FISH of a t(7;14) carrying metaphase cell demonstrating fusion of HOXA-TCRA/D gene regions (thin arrow). 
 
 
Figure 4: aCGH plot for chromosome 9 showing compound deletions. The light blue region indicates a terminal monoallelic 
deletion of 33.3 Mb of 9p while dark blue region points to biallelic deletion within the 9p21.3. 
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Comments 
The patient here presented with progressive cough 
and neck mass. He was found to have an elevated 
WBC count with concomitant anemia and 
thrombocytopenia. Assessment of peripheral blood 
revealed the diagnosis of T-cell acute lymphoblastic 
leukemia (T-ALL). Chromosome analysis showed 
two clones, pseudodiploid and pseudotetraploid, 
both exhibiting t(7;14)(p15;q11.2), del(6)(q14q21), 
and del(9)(p13) (Figure 1). However, the 
pseudotetraploid clone had two copies of these 
abnormalities indicating it was derived from 
duplication of the pseudodiploid clone. FISH 
confirmed juxtaposing of HOXA/7p15 and 
TCRD/14q11.2 genes in the t(7;14) carrying 
leukemic cells (Figure 3). 
Homeobox (HOX) genes encode transcription 
factors which act as key regulators in embryonic 
development and normal hematopoiesis. Recently, 
the HOXA gene cluster at chromosome 7p15 has 
been described as a new recurrent breakpoint that 
occurs in up to 3% of T-ALL. The inv(7)(p15q34) 
and t(7;7)(p15;q34) place HOXA under the control 
of T-cell specific enhancer of TCRB, leading to 
upregulation of HOXA genes particularly HOXA10 
and HOXA11. Another rare translocation is 
t(7;14)(p15;q11.2), previously described in a 29-
year-old patient with T-ALL. The translocation 
resulted in colocalization of HOXA-TCRD genes, 
and generalized overexpression of the HOXA 
genes. However the leukemic clone of this case had 
also t(10;11)(p14;q21), and expressed CALM-
AF10 fusion transcript. Therefore, it was concluded 
that the existence of both HOXA-TCRD and 
CALM-AF10 in the same leukemic cells may 
contribute to the global expression of HOXA genes. 
The t(7;14) in a 31-year old female with T-ALL 
was also cited but not well documented in a 
technical report by Garipidou et al 1991. 
The present case is believed to be the only other 
well described case with 
t(7;14)(p15;q11.2)/HOXA-TCRD translocation. 
However, our case was lacking t(10;11) which may 
make the two cases different in clinical presentation 
and response to therapy. Biallelic deletion of 
CDKN2A/9p21 as documented by aCGH and FISH 
was also found in our case (Figures 2, 4). Deletion 
of CDKN2A, tumor suppressor gene, is the most 
frequent genomic aberration occurs in over 70% of 
T-ALL which emphasizes the importance of 
CDKN2A inactivation in the development of this 
leukemia. A study pooling 907 individual cases of 
ALL has demonstrated that CDKN2A deletion, 
mono- or biallelic, is an independent risk factor for 
the development of ALL irrespective of cell lineage 
(B or T-cell). However, the prognostic significance 
of CDKN2A deletion in cases of pediatric T-cell 
ALL is currently unknown due to its frequent 
association with other recurrent cytogenetic 
abnormalities. The deletion CDKN2A/9p21 has 
been previously shown to accompany the common 
yet nonspecific finding of del(6q), which was also 
present in this case. 
In summary, the t(7;14)(p15;q11.2) translocation is 
extremely rare resulting in an aberrant juxtaposing 
of HOXA-TCRD genes. Therefore, TCRD/14q11.2 
may consider as a new variant partner for activation 
of HOXA/7p15 in T-ALL. Although the expression 
of HOXA genes was not tested in the present case, 
we assume it was upregulated as documented 
previously in HOXA-TCRD case and HOXA-
TCRB cases. 
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